Skip to content
Archive

MILESAX finalist project

MILESAX finalist project at the awards ceremony of “LE ECCELLENZE DELL’INFORMAZIONE SCIENTIFICA E LA CENTRALITA’ DEL PAZIENTE” organised by Merqurio Holding under the patronage of FNOMCeO as well as the Italian Ministry of Health.

Scientific information is the tool of choice for promoting projects that, in many cases, can improve patients’ quality of life. With this in mind, the award set out to recognise projects that have brought a real benefit to people’s health and decisive progress towards putting the patient at the centre, leaving the choice of the winners to the actual recipients of the information: doctors, who are the ones who actually care for patients.

The winners were identified through a selection process that began with 250,000 questionnaires sent to doctors, who were asked to point out ethical, excellent projects that were innovative and strongly focused on improving their patients’ quality of life.

A process with several stages of assessment led to a shortlist of 39 projects, divided into 8 categories (including nutraceuticals), which were put before the board, among them MILESAX, which received the finalist project certificate. Our project, named alongside 5 other projects from companies in the nutraceutical sector such as Mylan, Sigma Tau, Italfarmaco, Doc Generici and Camo, took 2nd place overall. A tremendous result.

We are proud to have been nominated, and this came about thanks to our dedication to the daily work of medical and scientific information, carried out to the highest standards of ethics, professionalism and excellence.

More news

  1. AIM Italia Conference 2018, Milan
  2. Medical prescriptions growing in 2018
  3. LISTING BONUS: the implementing Decree on the Tax Credit
Archive